Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES ALKEM LABORATORIES ZYDUS LIFESCIENCES/
ALKEM LABORATORIES
 
P/E (TTM) x 34.5 37.3 92.7% View Chart
P/BV x 5.8 6.5 89.8% View Chart
Dividend Yield % 0.6 1.0 58.1%  

Financials

 ZYDUS LIFESCIENCES   ALKEM LABORATORIES
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-23
ALKEM LABORATORIES
Mar-23
ZYDUS LIFESCIENCES/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs4953,625 13.7%   
Low Rs3192,835 11.3%   
Sales per share (Unadj.) Rs170.3970.1 17.6%  
Earnings per share (Unadj.) Rs19.884.2 23.5%  
Cash flow per share (Unadj.) Rs26.9110.2 24.4%  
Dividends per share (Unadj.) Rs6.0050.00 12.0%  
Avg Dividend yield %1.51.5 95.2%  
Book value per share (Unadj.) Rs173.0756.4 22.9%  
Shares outstanding (eoy) m1,012.20119.57 846.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.43.3 71.8%   
Avg P/E ratio x20.638.4 53.7%  
P/CF ratio (eoy) x15.129.3 51.6%  
Price / Book Value ratio x2.44.3 55.1%  
Dividend payout %30.359.4 51.1%   
Avg Mkt Cap Rs m412,144386,207 106.7%   
No. of employees `000NANA-   
Total wages/salary Rs m24,56421,314 115.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m172,374115,993 148.6%  
Other income Rs m4,7462,161 219.6%   
Total revenues Rs m177,120118,153 149.9%   
Gross profit Rs m29,67715,065 197.0%  
Depreciation Rs m7,2273,104 232.8%   
Interest Rs m1,2991,074 121.0%   
Profit before tax Rs m25,89713,048 198.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,8782,980 197.3%   
Profit after tax Rs m20,01910,068 198.8%  
Gross profit margin %17.213.0 132.6%  
Effective tax rate %22.722.8 99.4%   
Net profit margin %11.68.7 133.8%  
BALANCE SHEET DATA
Current assets Rs m100,08286,064 116.3%   
Current liabilities Rs m55,26737,071 149.1%   
Net working cap to sales %26.042.2 61.6%  
Current ratio x1.82.3 78.0%  
Inventory Days Days5033 154.3%  
Debtors Days Days9467 139.4%  
Net fixed assets Rs m144,77637,245 388.7%   
Share capital Rs m1,012239 423.3%   
"Free" reserves Rs m174,14690,208 193.0%   
Net worth Rs m175,15890,447 193.7%   
Long term debt Rs m00-   
Total assets Rs m244,940124,541 196.7%  
Interest coverage x20.913.2 159.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.9 75.6%   
Return on assets %8.78.9 97.3%  
Return on equity %11.411.1 102.7%  
Return on capital %15.515.6 99.4%  
Exports to sales %39.214.6 268.8%   
Imports to sales %11.90-   
Exports (fob) Rs m67,57716,916 399.5%   
Imports (cif) Rs m20,544NA-   
Fx inflow Rs m67,57716,916 399.5%   
Fx outflow Rs m20,5444,190 490.4%   
Net fx Rs m47,03312,727 369.6%   
CASH FLOW
From Operations Rs m26,88816,825 159.8%  
From Investments Rs m11,7121,128 1,037.9%  
From Financial Activity Rs m-44,004-17,608 249.9%  
Net Cashflow Rs m-5,338416 -1,282.6%  

Share Holding

Indian Promoters % 75.0 56.7 132.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 18.0 24.4 73.9%  
FIIs % 5.0 8.5 58.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 43.3 57.8%  
Shareholders   306,495 65,184 470.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on Cadila Healthcare vs ALKEM LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs ALKEM LABORATORIES Share Price Performance

Period Cadila Healthcare ALKEM LABORATORIES S&P BSE HEALTHCARE
1-Day 1.42% -1.85% 1.18%
1-Month 8.68% -1.67% -0.75%
1-Year 109.28% 51.22% 61.82%
3-Year CAGR 32.67% 21.42% 18.16%
5-Year CAGR 24.73% 22.82% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the ALKEM LABORATORIES share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of ALKEM LABORATORIES the stake stands at 56.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of ALKEM LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 30.3%.

ALKEM LABORATORIES paid Rs 50.0, and its dividend payout ratio stood at 59.4%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of ALKEM LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.